Skip to main content
. 2022 Nov 14;2022(11):CD012956. doi: 10.1002/14651858.CD012956.pub2

12.4. Analysis.

12.4

Comparison 12: Single medication compared with alternate single medication ‐ non‐serious adverse events ‐ central nervous system, Outcome 4: Sleepiness/drowsiness